Clinical Trial Update: A Study to Evaluate Serum Testosterone Levels in Patients With Metastatic Castration-Resistant Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial assessing serum testosterone levels in metastatic castration-resistant prostate cancer patients has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Sun Pharmaceutical Industries Limited | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-08-12